Metrics for Phased Reopening

Contact us

As the COVID-19 pandemic continues, local leaders across the United States are working to bolster public health capacity and take some initial steps to reopen — protecting their communities from the disease and supporting economic recovery and growth. Below, COVID-Local provides decision-makers with easy-to-use metrics for a phased re-opening strategy. These metrics can be used to assess existing response, pinpoint areas for action, and make decisions for moving to the next phase of re-opening. The graphics in the Metrics Overview describe phases and the key metrics associated with each phase under a set of public health categories. The Scorecard (found on the Metrics Scorecard tab and available as a PDF download) can be used to self-assess community progress across all metrics for each Phase. The Assess Your Progress tab provides a series of graphics with phase-specific metrics. The interactive checklist can be used to show progress toward meeting thresholds for each phase.

Lockdown1432PHASES FOR RE-OPENINGPhase 4: New normal • Maximal return to normalcy that is viable prior to herd immunity via widespread vaccination• Community transmission is well monitored and virus flare-ups are contained rapidly • Most high-risk/low criticality functions can resume Phase 3: Economic recovery • Widely re-opening economic and social functions once transmission has declined and is suppressed • Moderate-sized gatherings and activities in enclosed spaces possible with appropriate mitigation• Continue to prohibit large gatherings• Telework should continue wherever feasiblePhase 2: Initial re-opening • Limited number of critically important activities open• Continue to prohibit gatherings in enclosed spaces• Some outdoor activities with appropriate distancing • Telework should continue wherever feasiblePhase 1: Maximum social-distancing Tailored to each community, focus is on reducing person-to-person transmission and decreasing the burden on the healthcare systemFULL PHASE DESCRIPTIONFULL PHASE DESCRIPTIONFULL PHASE DESCRIPTIONFULL PHASE DESCRIPTIONProtecting At-Risk PopulationsHealthcare ReadinessCase & Contact InvestigationsDiagnosticTesting & SurveillanceInfection RateCurrent estimate of less than 1 caseper 100,000 population per week<3% of tests conducted are positiveContinued decline in daily cases<3% of tests conducted are positiveCurrent estimate of less than 1 caseper 100,000 population per daySustained decline in daily cases for 21 consecutive days, as reflected in the 5-day rolling average<10% of tests conducted are positiveCurrent estimate of less than 5 casesper 100,000 population per dayRates & New Cases DecreasingRates & New Cases Increasing